-
Loading metrics
Open Access
Peer-reviewed
Research Article
11β-Hydroxysteroid Dehydrogenase Type 1 Gene Knockout Attenuates Atherosclerosis and In Vivo Foam Cell Formation in Hyperlipidemic apoE−/− Mice
-
Ricardo A. García,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Debra J. Search,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
John A. Lupisella,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Jacek Ostrowski,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Bo Guan,
Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Jian Chen,
Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Wen-Pin Yang,
Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Amy Truong,
Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Aiqing He,
Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Rongan Zhang,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Mujing Yan,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Samuel E. Hellings,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Peter S. Gargalovic,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Carol S. Ryan,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Linda M. Watson,
Affiliation Pharmaceutical Compound Optimization: Discovery Toxicology, Bristol-Myers Squibb Company, Lawrenceville, New Jersey, United States of America
⨯ -
Robert A. Langish,
Affiliation Pharmaceutical Compound Optimization: Discovery Analytical Sciences, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Petia A. Shipkova,
Affiliation Pharmaceutical Compound Optimization: Discovery Analytical Sciences, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Nancy L. Carson,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Joseph R. Taylor,
Affiliation Metabolic Diseases, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Richard Yang,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
George C. Psaltis,
Affiliation Veterinary Sciences, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Thomas W. Harrity,
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ -
Jeffrey A. Robl,
Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ - [ ... ],
-
David A. Gordon
* E-mail: david.gordon@bms.com
Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America
⨯ - [ view all ]
- [ view less ]
11β-Hydroxysteroid Dehydrogenase Type 1 Gene Knockout Attenuates Atherosclerosis and In Vivo Foam Cell Formation in Hyperlipidemic apoE−/− Mice
- Ricardo A. García,
- Debra J. Search,
- John A. Lupisella,
- Jacek Ostrowski,
- Bo Guan,
- Jian Chen,
- Wen-Pin Yang,
- Amy Truong,
- Aiqing He,
- Rongan Zhang
- Published: February 1, 2013
- https://doi.org/10.1371/journal.pone.0053192